Earnings
NMTR
1.400
-2.10%
-0.030
Currencies: USD
Items
Net Income
Depreciation and Amortization
Deferred Tax
Unamortized Expenditures
Accrued Expenses
Share-based Compensation
Assets Disposal
Financial Expenses
Investment Loss
Working Capital Change
Other Items
Operating Activities
Purchases of Fixed Assets
Proceeds from Disposal of Fixed Assets
Investment Expenditure
Investment Income
Other Investing Activities
Investing Activities
Issuance of Capital Stock
Issuance of Bonds
Proceeds from Borrowings
Dividend Payments
Repayment of Borrowings
Buyback Payments
Stock Incentive Compensation
Other Financing Activities
Financing Activities
Effect of Exchange Rate Changes 
Net Increase in Cash,Cash Equivalents
FY 2020-12-31
-61.50M
18.49K
--
--
--
--
41.29M
--
--
775.49K
--
-19.41M
-2540.00
--
--
--
-3.18M
-3.19M
62.24M
38.53K
--
--
--
--
--
--
55.86M
--
33.26M
FY 2019-12-31
-27.05M
21.61K
--
--
--
--
5.16M
--
--
3.89M
--
-17.97M
-11.93K
--
--
--
0.00
-11.93K
20.74M
-2.79M
--
--
--
--
--
--
16.84M
--
-1.14M
FY 2018-12-31
-24.16M
19.56K
--
--
--
--
9.63M
--
--
-653.36K
--
-15.17M
-13.94K
--
--
--
0.00
-13.94K
17.75M
3.07M
--
--
--
--
--
--
20.56M
--
5.37M
FY 2017-12-31
-7.92M
131.00K
--
--
--
--
2.31M
--
--
1.49M
--
-4.00M
--
--
--
--
--
--
1.61M
1.45M
--
--
--
--
--
--
2.98M
--
-1.03M
FY 2016-12-31
-6.21M
131.00K
--
--
--
--
1.30M
--
--
-3.65M
--
-8.43M
--
--
--
--
--
--
11.22M
-248.00K
--
--
--
--
--
--
9.76M
--
1.33M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out NMTR latest annual and quarterly financial reports. There are also historical financial reports for you to reference. You can analyze 9 Meters Biopharma recent business situations by check its cash flow statements, balance sheets, income statements and other tables. Comprehensive data may help you to understand and analyze NMTR development prospects in various aspects, and this information may help you to better grasp the 9 Meters Biopharma operation.